For the first time, the holy month of Ramadan is taking place in what could only be described as the GLP-1 era, where appetite suppression has gone from niche medical treatment to the ultimate life hack for weight loss overnight. This moment feels like a cultural shift. Hunger, once the central physical experience of fasting, no longer behaves in a uniform way. Walk into any iftar this year and you can almost play a guessing game: who’s fasting on willpower alone, and who’s fasting with pharmaceutical assistance.
The scale of the shift is not imaginary. In the Gulf, where obesity and diabetes rates are among the highest in the world, demand has been intense enough to trigger periodic shortages, according to regional health authorities and pharmacy reports across the UAE and Saudi Arabia. While precise public figures are scarce, clinicians in the region have repeatedly noted a dramatic spike in non-diabetic patients seeking prescriptions for weight loss. In other words, this is not a niche subculture, it is mainstream.
Which raises a surprisingly spicy question during Ramadan, or any modern spiritual and wellness ritual involving not eating: if you’re fasting while taking Ozempic, Mounjaro, or any GLP-1 that suppresses appetite, is that technically cheating?
The short answer is no. The long answer is, well, very 2026.
Religious fasting is about intention, discipline, reflection, and empathy, not about suffering as efficiently as possible. Medical fasting protocols focus on metabolic benefits, insulin sensitivity, and cellular repair. Neither framework includes a clause about pharmaceutical appetite suppression invalidating the experience.
Semaglutides (Ozempic and Wegovy), tirzepatides (Mounjaro and Zepbound), and dulaglutides (Trulicity) work by mimicking a hormone called GLP-1, which regulates blood sugar and appetite. They slow gastric emptying, reduce hunger signals, and make you feel full on dramatically less food. That is precisely why fasting on them can feel bizarrely easy compared to the white-knuckle endurance many people are used to.
Heather Mills, entrepreneur and founder of a Monash-certified low-FODMAP food range, has warned that these medications were originally designed for specific medical conditions, not general lifestyle use. In her view, they should not be taken “without proper medical need and careful consideration,” especially given the growing trend of people using them as quick fixes driven by social pressure rather than health necessity.
GLP-1 medications do not just make you less hungry, they fundamentally change how your body processes food and energy. They stimulate insulin release when blood sugar rises, reduce glucagon production, and slow digestion so glucose enters the bloodstream more gradually. In practical terms, this means your body experiences fewer dramatic hunger spikes and crashes during the day, so what feels like saint-level restraint might actually be smoother glucose control doing the heavy lifting behind the scenes.
Still, “easy fasting” is not automatically safe fasting. Appetite suppression can backfire when the eating window arrives. Many users struggle to consume enough calories, protein, and micronutrients even when they are allowed to eat, which becomes more complicated during religious fasts that compress meals into narrow timeframes. Mills notes that some individuals on GLP-1s eat as little as 800 calories daily, and a significant portion of weight loss may come from muscle rather than fat if protein intake is insufficient. For someone fasting from sunrise to sunset, that risk compounds quickly.
While fasting on GLP-1s is not cheating, it can be nutritionally precarious if you are not intentional. The body still needs amino acids to preserve muscle, electrolytes to maintain fluid balance, and vitamins to keep hormonal systems functioning. Skipping suhoor because you aren’t hungry might feel efficient, but it is essentially inviting dehydration, fatigue, and nutrient depletion to the party.
Side effects can also blur the line between fasting symptoms and medication reactions. Nausea, vomiting, diarrhea, abdominal pain, and dehydration are all documented effects of GLP-1 drugs, says Mills. During a fast, those sensations may intensify because you cannot easily rehydrate or settle your stomach. What you interpret as spiritual lightness could actually be low blood pressure and electrolyte imbalance.
There is also a psychological layer that nobody loves to admit. Fasting traditionally involves confronting hunger, impatience, irritability, and vulnerability, which are supposed to foster empathy for those who live with scarcity daily. When medication removes that struggle, some people feel oddly disconnected from the ritual. Others experience relief that they can participate without physical distress.
Control is the real theme of the GLP-1 era. These medications arrived at a moment when food environments are engineered for overconsumption and beauty standards remain stubbornly unforgiving. They promise mastery over appetite in a culture that constantly overstimulates it. Using them during a fast does not negate the spiritual intention, but it does transform the experience into something distinctly modern: devotion mediated by pharmacology.
If you are fasting while on Ozempic or Mounjaro, practical strategies matter. Prioritize protein at your first meal even if you can only tolerate small portions, hydrate aggressively during non-fasting hours because these drugs can disrupt fluid balance, and consider electrolyte solutions rather than plain water alone. Mills recommends full panels every few months for those on GLP-1s, including vitamin and hormone checks.
Most importantly, listen to your body without treating discomfort as a flex. Religious traditions consistently allow exemptions for illness, pregnancy, and medical necessity for a reason. Islam prioritizes health and ease over hardship, so you are permitted to break or skip your fast during Ramadan if you are sick and allowed to make up the missed days later.
So, is fasting on Ozempic cheating? Only if you believe hunger itself is the goal rather than the vehicle. As one friend on Mounjaro bluntly put it: “It depends why you’re taking it. If you can’t stop snacking and you think about food from the moment you open your eyes to when you fall asleep… then yeah maybeeeeee. But for girlies struggling with hormonal issues we’re just out here fighting for our lives, we deserve a win where we can get one.” Her point highlights something often lost in the discourse: not everyone taking these medications is chasing aesthetic goals. For some, they are managing conditions like insulin resistance, PCOS, or chronic appetite dysregulation that make traditional dieting nearly impossible.
More importantly, not eating and not drinking were never meant to be the only pillars of fasting, just the most visible ones. Ramadan asks for restraint in far subtler ways that no injection can regulate, like patience when you are irritated, control over anger, gossip, scrolling, spending, ego, and every other impulse that tends to run on autopilot the rest of the year. For many people, those are the difficult parts.
GLP-1s can quiet hunger signals, but they cannot manufacture empathy, discipline, or intention. They cannot make you kinder, calmer, more present, or more accountable for your behavior. They do not help you wake up for suhoor, apologize first, donate more, pray more consistently, or resist the urge to snap at someone in traffic at 5 p.m. when the day feels endless. In that sense, the core sacrifices of Ramadan remain stubbornly analog.